FFO
INMB icon

Fortitude Family Office’s INmune Bio INMB Stock Holding History

Fortitude Family Office’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129 Buy
+79
New +$109 ﹤0.01% 2151

Other funds holding INMB

CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Fortitude Family Office's INMB Position: Q2 2026 in Review

Fortitude Family Office opened a new position in INmune Bio (INMB) in Q2 2026: 79 shares worth $129. The stake represents ﹤0.01% of the portfolio and ranks #2151 among its holdings.

11 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Fortitude Family Office held 79 shares of INmune Bio worth $129 as of Q2 2026.
  • INmune Bio was a new Fortitude Family Office position in Q2 2026.
  • INmune Bio made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2151 holding.
  • 11 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.